Sewoon Medical Co., Ltd (KOSDAQ:100700)
South Korea
· Delayed Price · Currency is KRW 2,900.00
-10.00 (-0.34%)
At close: Apr 28, 2026
Sewoon Medical Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 63,657 | 60,151 | 68,247 | 60,116 | 62,579 | Upgrade
|
| Other Revenue | - | - | -0 | - | - | Upgrade
|
| Revenue | 63,657 | 60,151 | 68,247 | 60,116 | 62,579 | Upgrade
|
| Revenue Growth (YoY) | 5.83% | -11.86% | 13.53% | -3.94% | -1.80% | Upgrade
|
| Cost of Revenue | 40,112 | 37,963 | 40,689 | 37,896 | 37,522 | Upgrade
|
| Gross Profit | 23,545 | 22,188 | 27,557 | 22,220 | 25,057 | Upgrade
|
| Selling, General & Admin | 9,454 | 9,468 | 9,330 | 8,734 | 8,466 | Upgrade
|
| Research & Development | 456.39 | 510.42 | 468.21 | 505.09 | 427.87 | Upgrade
|
| Amortization of Goodwill & Intangibles | 242.33 | 149.71 | 143.91 | 152.41 | 87.82 | Upgrade
|
| Operating Expenses | 10,844 | 10,811 | 10,637 | 10,033 | 9,671 | Upgrade
|
| Operating Income | 12,701 | 11,377 | 16,920 | 12,187 | 15,386 | Upgrade
|
| Interest Expense | -35.52 | -36.63 | -36.08 | -35.81 | -31.47 | Upgrade
|
| Interest & Investment Income | 2,065 | 2,331 | 1,969 | 736.18 | 172.83 | Upgrade
|
| Currency Exchange Gain (Loss) | 143.09 | 1,597 | 357.41 | 702.87 | 1,035 | Upgrade
|
| Other Non Operating Income (Expenses) | -7.96 | 73.35 | 69.67 | 38.25 | 67.05 | Upgrade
|
| EBT Excluding Unusual Items | 14,865 | 15,342 | 19,280 | 13,629 | 16,630 | Upgrade
|
| Gain (Loss) on Sale of Assets | 36.61 | 279.54 | 17.79 | 2.2 | -0.67 | Upgrade
|
| Asset Writedown | - | - | - | -2 | -2.96 | Upgrade
|
| Pretax Income | 14,902 | 15,621 | 19,298 | 13,629 | 16,626 | Upgrade
|
| Income Tax Expense | 2,709 | 3,046 | 3,824 | 2,990 | 3,864 | Upgrade
|
| Earnings From Continuing Operations | 12,193 | 12,575 | 15,474 | 10,639 | 12,762 | Upgrade
|
| Net Income to Company | 12,193 | 12,575 | 15,474 | 10,639 | 12,762 | Upgrade
|
| Minority Interest in Earnings | -280.57 | -412.61 | -517.02 | -232.69 | -480.5 | Upgrade
|
| Net Income | 11,912 | 12,163 | 14,957 | 10,406 | 12,282 | Upgrade
|
| Net Income to Common | 11,912 | 12,163 | 14,957 | 10,406 | 12,282 | Upgrade
|
| Net Income Growth | -2.06% | -18.68% | 43.73% | -15.27% | 17.02% | Upgrade
|
| Shares Outstanding (Basic) | 43 | 43 | 43 | 43 | 43 | Upgrade
|
| Shares Outstanding (Diluted) | 43 | 43 | 43 | 43 | 43 | Upgrade
|
| Shares Change (YoY) | -1.36% | -0.02% | - | - | - | Upgrade
|
| EPS (Basic) | 279.00 | 281.00 | 345.50 | 240.38 | 283.70 | Upgrade
|
| EPS (Diluted) | 279.00 | 281.00 | 345.50 | 240.38 | 283.70 | Upgrade
|
| EPS Growth | -0.71% | -18.67% | 43.73% | -15.27% | 17.02% | Upgrade
|
| Free Cash Flow | 16,083 | 11,750 | 21,127 | 7,128 | 19,244 | Upgrade
|
| Free Cash Flow Per Share | 376.68 | 271.47 | 488.02 | 164.65 | 444.53 | Upgrade
|
| Dividend Per Share | - | - | 70.000 | 60.000 | 50.000 | Upgrade
|
| Dividend Growth | - | - | 16.67% | 20.00% | - | Upgrade
|
| Gross Margin | 36.99% | 36.89% | 40.38% | 36.96% | 40.04% | Upgrade
|
| Operating Margin | 19.95% | 18.91% | 24.79% | 20.27% | 24.59% | Upgrade
|
| Profit Margin | 18.71% | 20.22% | 21.92% | 17.31% | 19.63% | Upgrade
|
| Free Cash Flow Margin | 25.26% | 19.54% | 30.96% | 11.86% | 30.75% | Upgrade
|
| EBITDA | 16,021 | 14,857 | 20,568 | 16,075 | 19,222 | Upgrade
|
| EBITDA Margin | 25.17% | 24.70% | 30.14% | 26.74% | 30.72% | Upgrade
|
| D&A For EBITDA | 3,320 | 3,480 | 3,648 | 3,888 | 3,836 | Upgrade
|
| EBIT | 12,701 | 11,377 | 16,920 | 12,187 | 15,386 | Upgrade
|
| EBIT Margin | 19.95% | 18.91% | 24.79% | 20.27% | 24.59% | Upgrade
|
| Effective Tax Rate | 18.18% | 19.50% | 19.82% | 21.94% | 23.24% | Upgrade
|
| Advertising Expenses | 281.21 | 294.06 | 233.54 | 186.34 | 76.21 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.